publication date: Jun. 5, 2015

Robinson Named Fred Hutch VP of Industry Relations

 

NICOLE ROBINSON will lead the Industry Relations and Technology Transfer office at Fred Hutchinson Cancer Research Center. Robinson will begin her role as vice president of industry relations and business development on July 27.

Robinson comes from Cincinnati Children’s Hospital Medical Center where she served as assistant vice president of the Center for Technology Commercialization, leading the technology transfer and commercialization development team. During her nine years at Cincinnati Children’s, Robinson increased the medical center’s invention disclosures tenfold while doubling the active commercial licenses executed, resulting in over $60 million in licensing revenue. Prior to that, she managed IP assets for the Office of Technology and Intellectual Property at the University of Chicago.

The Industry Relations and Technology Transfer Office is responsible for managing and commercializing the intellectual property assets of Fred Hutch. The activities of the office span the technology transfer process—including invention disclosure, market evaluation, intellectual property protection, licensing and contract management, and collaborations with industry and venture partners.

 

THE DEPARTMENT OF DEFENSE appropriations bill for the 2016 fiscal year includes an additional $12 million for lung cancer research under the Congressionally Directed Medical Research Program. The bill has been approved by the House Appropriations Committee.

This is an increase of nearly 15 percent over last year, bringing the total amount of federal funding secured to-date to $101.5 million, according to the Lung Cancer Alliance. The bill is expected to be considered by the House in the coming weeks.

Continue reading 41-22 Robinson Named Fred Hutch VP of Industry Relations

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.